In vitro and in vivo studies of cellular lysis of oral bacteria by a lysozyme-protease-inorganic monovalent anion antibacterial system.
Compared with anion-activated cell lysis of oral bacteria damaged with either lysozyme or trypsin, cells which were treated with both of these enzymes showed a far greater degree of lysis. This was true regardless of whether turbidimetric, DNA release, or electron microscopic assays were used to monitor the lytic process. At an acidic pH of 5.2 and an NaHCO3 concentration of 100 mM, the kinetics of lysis for two different serotype c strains of Streptococcus mutans were similar. At 0 to 100 mM bicarbonate, however, differences in the lytic susceptibilities of the two strains were evident. At pH 5.2, NaHCO3, but not NaSCN, NaCl, or NaF, was effective in promoting cell lysis of the oral bacteria. At apparent sublytic concentrations of NaHCO3, lysis was achieved by adding appropriate concentrations of NaSCN, NaCl, or NaF to the lysozyme-protease-damaged cells. In in vivo studies, hamsters given a combination of NaHCO3, NaCl, and NaSCN were found to have significantly reduced levels of S. mutans on their molar teeth compared with that found in controls or animals exposed to any one of the salts alone or to a combination of chloride and thiocyanate only. The results suggest that bicarbonate is an essential anion which, together with the other major salivary inorganic monovalent anions, plays an active role in the lysis and ultimate elimination of cariogenic bacteria.
D000190:Actinomyces / Q000254:growth & development*; D000818:Animals; D001639:Bicarbonates / Q000627:therapeutic use; D006224:Cricetinae; D003773:Dental Plaque / Q000382:microbiology* / Q000628:therapy; D005459:Fluorides / Q000627:therapeutic use; D006863:Hydrogen-Ion Concentration; D007780:Lacticaseibacillus casei / Q000254:growth & development*; D009113:Muramidase / Q000627:therapeutic use; D013295:Streptococcus mutans / Q000254:growth & development*; D013861:Thiocyanates / Q000627:therapeutic use; D014357:Trypsin / Q000627:therapeutic use
D001639:Bicarbonates; D013861:Thiocyanates; D009113:Muramidase; D014357:Trypsin; D005459:Fluorides